Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Nächster Kursturbo?: 226 % Plus seit Januar - wie weit kann diese Aktie noch steigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D495 | ISIN: CA13765U2002 | Ticker-Symbol: 8CB0
Frankfurt
30.06.25 | 08:07
0,805 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CANNARA BIOTECH INC Chart 1 Jahr
5-Tage-Chart
CANNARA BIOTECH INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,8250,92515:00

Aktuelle News zur CANNARA BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CANNARA BIOTECH Aktie jetzt für 0€ handeln
19.06.Cannara Biotech Inc (2): Cannara Biotech to hold investor webcast June 251
19.06.Cannara Biotech (Québec) Inc.: Cannara Biotech to Host Investor Webcast on June 25th, 20251
18.06.Cannara Biotech Inc (2): Cannara repays $1-million of convertible debenture5
18.06.Cannara Biotech (Québec) Inc.: Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year1
28.04.Cannara Biotech reports Q1 results4
16.04.Cannara Biotech Inc (2): Cannara Biotech to release Q2 2025 results April 281
16.04.Cannara Biotech (Québec) Inc.: Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 20251
24.03.Cannara Biotech Inc (2): Cannara appoints Cohen as director1
24.03.Cannara Biotech (Québec) Inc.: Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors1
27.01.Cannara Biotech GAAP EPS of C$0.03, revenue of C$25.1M5
25.11.24Cannara Biotech (Québec) Inc.: Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market231Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023.Robust growth in Q4 over Q3 2024, with total revenues...
► Artikel lesen
16.08.24Cannara Biotech Inc.: Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024159MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and...
► Artikel lesen
23.07.24Cannara Biotech Inc.: Cannara Biotech Reports Q3 2024 Financial Results407Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased to...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1